Why Medical Cannabis Is Still So Hard to Access in the UK — And What You Can Do

The Access Problem Nobody Is Fixing

Medical cannabis has been legal in the UK since November 2018 — yet getting a prescription remains, for most patients, an exhausting, expensive and often heartbreaking process. A May 2026 investigation by The Guardian asked the same question patients have been asking for years: why, after a hard-fought legal victory, is access still so difficult?

The answer is complicated, and it involves the NHS, private clinics, the MHRA, prescribing guidelines, and a healthcare system that was never truly designed to accommodate cannabis-based medicines at scale.

The NHS Wall

The NHS route to medical cannabis exists on paper. In practice, it is almost closed. Prescriptions via the NHS require a specialist in the relevant condition (neurology for epilepsy, oncology for cancer-related pain, etc.) to initiate the prescription, and that specialist must be convinced by the evidence base — which NICE guidelines currently rate as limited for most conditions.

Fewer than 10 NHS cannabis prescriptions were issued in England in 2024. The result is that virtually all patients who receive medical cannabis in the UK pay for it privately — often spending £150–£350 per month on prescriptions and consultations.

The Private Sector: Progress, But at a Price

The private sector has stepped in to fill the gap, and 2026 has seen significant growth — more than 30 licensed providers, tens of thousands of patients, and falling consultation costs. But barriers remain:

• Cost: consultation fees of £50–£200, plus ongoing prescription costs of £100–£300/month
• Eligibility: clinics require previous treatment with conventional medicines — often a 12-month trail first
• Awareness: GPs rarely mention cannabis as an option, leaving patients to find their own way
• Stigma: patients still report GPs who refuse to engage or who express disapproval

What Has Actually Improved?

It is not all bad news. Project Twenty21, the UK’s largest real-world evidence study, showed that medical cannabis significantly improved quality of life for patients with pain, anxiety, PTSD and sleep disorders. In 2026, several insurers began exploring coverage, and at least one major employer has updated its drug policy to accommodate prescribed cannabis.

The clinical evidence base is growing. The argument that there is “insufficient evidence” is becoming harder to sustain as thousands of UK patients report improvement with carefully managed prescriptions.

How to Get Access in 2026

If you are considering medical cannabis and wondering how to navigate the system, here is the realistic path:

1. Document your condition — gather your medical history, previous treatments tried, and their results
2. Speak to your GP — they cannot prescribe cannabis but can provide useful referrals and documentation
3. Choose a specialist clinic — select a CQC-registered provider with GMC-registered doctors in your area
4. First consultation — typically remote (video call), 30–60 minutes, assessment of eligibility
5. Prescription — if approved, dispensed via a registered pharmacy and delivered to your home

For a full walkthrough of the process, our step-by-step guide to getting a UK prescription covers every stage. To understand costs in detail, see our breakdown of what medical cannabis costs in the UK.

Conditions With the Strongest Case for Access

The evidence base varies by condition. The conditions with the strongest clinical case for medical cannabis in the UK include:

• Chronic pain (particularly neuropathic pain)
• Treatment-resistant epilepsy
• Multiple sclerosis spasticity
• PTSD and anxiety disorders
• Chemotherapy-induced nausea and vomiting
• Sleep disorders

For condition-specific guides, explore our pages on cannabis for chronic pain and cannabis for anxiety in the UK.

The Argument for Reform

The access problem will not solve itself. Campaigners are calling for NHS guidance to be updated, for NICE to reflect the growing real-world evidence, and for GP training to include cannabis literacy. Until that happens, private clinics remain the practical route for most UK patients — imperfect, but available.